Moxifloxacin retains antimycobacterial activity in the presence of gyrA mutations. [electronic resource]
- Antimicrobial agents and chemotherapy May 2014
- 2912-5 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1098-6596
10.1128/AAC.02583-13 doi
Antitubercular Agents--pharmacology Bacterial Proteins--genetics DNA Gyrase--genetics Drug Resistance, Bacterial--genetics Fluoroquinolones--pharmacology Microbial Sensitivity Tests Moxifloxacin Mutation Mycobacterium tuberculosis--drug effects